Oruka Therapeutics (HQ1.F) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.38
-1.04
-0.7
-0.36

Details

Expected EPS
-0.45435311873
Actual EPS
-0.357524
Surprise EPS
0.1
Surprise Percent
+21.31%

Description

Oruka Therapeutics (HQ1.F) has reported earnings of -0.357524 per share for Q2 2025.

0 Comments

Share your thoughts